14.10.2016 • News

Reverdia and Xinhuarun to Develop Bio-based PU Foams

(c) AVAVA/Shutterstock
(c) AVAVA/Shutterstock

Dutch biochemicals specialist Reverdia has signed an agreement with China’s Dezhou Xinhuarun Technology to jointly develop and promote microcellular PU foams based on bio-succinic acid. Reverdia’s Biosuccinium will be used in the foams which go into manufacturing footwear, shoe soles and other applications.

Liang Yanzhi, chair of the board at Xinhuarun, said the Dezhou, Shandong-based company will work exclusively with Reverdia. She commented: “Going forward, we will expand our work with Reverdia towards development and commercialization of other sustainable polymers in our strategic markets. These innovative materials address a potential market in excess of $500 million.

A joint venture between Royal DSM and French family-owned firm Roquette Frères, Reverdia is dedicated to the market development of Biosuccinium, which is based on renewable, plant-based resources. Reverdia began licensing the product and technology in 2014.

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups
Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read